Reduced form of CoenzymeQ10 for Parkinson's disease - open trial of dose finding test and combination with hydrogen water

Not Applicable

• Conditions: Parkinson' s disease

• Registration Number: JPRN-UMIN000019090
• Lead Sponsor: Juntendo University Koshigaya Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-11-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Not provided

Exclusion Criteria

presence of parkinsonism unrelated to PD, dementia or other serious disease, malignant tumor, a history of brain surgery, and adverse events caused by medications. modified Hoehn and Yahr stage 4 and 5 without allergy for medication

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The differences from baseline to 16th week of MDS-UPDRS part III and plasma % coenzyme Q10(CoQ10)

Secondary Outcome Measures

Name	Time	Method
The differences of each parts or total of MDS-UPDRS The differences of urine 18OH-dG The differences of plasma reduced form of CoQ10